Anti-Malarial Drugs Market: By Drug Type - (Quinine, Chloroquine, Pyrimethamine, Amodiaquine, Proguanil, Mefloquine, Sulfonamide, Artemisinin & derivatives, Atovaquone, Primaquine, Halofantrine, Doxycycline, and Clindamycin); By Malaria Type - (Plasmodium
Life ScienceRequest PDF Sample Request Free Customization
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Anti-Malarial Drugs MarketRequest Sample
The anti-malarial drugs market is anticipated to flourish at a CAGR of 3.8% over the forecast period i.e. 2020-2025. Further, the market for anti-malarial drugs was valued at USD XXX.X Million in 2020.
Growth Drivers – Anti-Malarial Drugs Market
Increasing Cases of Malaria
According to World Health Organization, there were 219 million cases of malaria across the world in 2018. This represented an increase of 2 million as compared to 2016. Moreover, malaria resulted in death of 435 thousand people and children in 2016. Further, government initiatives and healthcare organizations attempt to reduce case of malaria is expected to positively impact the growth of global anti-malarial drugs market.
Increasing Anti-Malaria Products Discovery Projects
Continuous growth in research and development activities is anticipated to positively impel the growth of global anti-malarial drugs market. Apart from this, favourable support from government and funding from other organization is resulting in increased research and development activities. This factor is envisioned to bolster the growth of global anti-malarial drugs market.
Barriers – Anti-Malarial Drugs Market
Associated Side Effects with Anti-malarial Drugs
Factors such as possible side effects of malaria drugs including insomnia, dizziness, anxiety and others are anticipated to hamper the growth of global anti-malarial drugs market.
The anti-malarial drugs market by drug type is segmented into quinine, chloroquine, pyrimethamine, amodiaquine, proguanil, mefloquine, sulfonamide, artemisinin & derivatives, atovaquone, primaquine, halofantrine, doxycycline, and clindamycin. The market for quinine is anticipated to witness significant growth during the forecast period.
Further, global anti-malarial drugs market is also segmented by distribution channel into hospital pharmacy, retail pharmacy, e-commerce, and others. Retail pharmacy segment captured significant market share during the forecast period. Further, e-commerce segment is anticipated to witness highest growth in the upcoming years.
Geographically, the report offers analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In anti-malarial drugs market, Middle East & Africa captured the largest percentage of market in global anti-malarial drugs market. With a market share of approximately 47.3% in 2020, MEA market contributed majorly in global anti-malarial drugs market. According to WHO, Sub-Saharan Africa accounted for 90% of malaria deaths worldwide in 2013. In addition, DRC and Nigeria accounted for more than 40% deaths from malaria in the region. Asia Pacific anti-malarial drugs market is anticipated to witness robust growth during the forecast period. South East Asia has highest number of malaria cases after African region. Further, government of South East Asian countries and various healthcare organizations are making significant investment to reduce cases and deaths from malaria. This factor is envisioned to bolster the growth of Asia anti-malarial drugs market.
The report profiles various major market players such as;
- GlaxoSmithKline Plc
- Ranbaxy Laboratories
- Zydus Cadila
- Alvizia Health Care
- Bayer AG
- Pfizer, Inc.
- Ipca Laboratories Ltd
- Merck KGaA
- F. Hoffmann-La Roche AG
- Novartis AG
- Other Major & Niche Players
Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities).
The study also provides company’s positioning and market share in anti-malarial drugs market.
Timeline Considered for Analysis:
- 2014 to 2018: Historical Review
- 2020: Base Year
- 2020 to 2025: Forecast Period
Research Scope and Deliverables
Overview & Executive Summary
Market Drivers, Trends, Challenges and Opportunities
Market Size and Forecast Projections
Macroeconomic Indicators of Various Countries Impacting the Growth of the Market
Extensive Coverage of Industry Players including Recent Product Launches and Market Activities
Porter’s Five Force Analysis
Market Segmentation Analysis:
Industry report analyzes the global anti-malarial drugs market by the following segments:
- Drug Type
- Malaria Type
- Distribution Channel
Customization: We also offers customization’s in the industry report as per the company’s specific needs.
Key Questions Answered in the Global Anti-Malarial Drugs Industry Report:
- What is the overall market size in 2019? What will be the market growth during the forecast period i.e. 2020-2025?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?
Custom Research Requirement? Questions to ask?Get in touch
Custom Research requirement.